Application no. and date | 11164516.4 (espacenet) (Federated) (European Patent Register), 20070703 | Patent/reg. no. and date | DK/EP 2359826, 20131030 | Publication date | 20110824 | Priority no. and date | EP 06116625, 20060705 | EP pub. no. and date |
EP 2359826 20110824 | Effective date | | Applicant/owner | AstraZeneca AB, SE 151 85 Södertälje, SE | Applicant ref. no. | P53060DK01 | Inventor | Marx, Degenhard, Obere Reute 15
78345, Moos, DE, Wollin, Stefan-Lutz, Mälzergasse 3
88339, Bad Waldsee, DE, Wohlsen, Andrea, Steubenring 6
53175, Bonn, DE, Braun, Clemens, Obere Au 7
88400 Biberach, DE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/22 (2006.01) , A61K 31/277 (2006.01) , A61K 31/343 (2006.01) , A61K 31/352 (2006.01) , A61K 31/366 (2006.01) , A61K 31/40 (2006.01) , A61K 31/405 (2006.01) , A61K 31/437 (2006.01) , A61K 31/44 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/453 (2006.01) , A61K 31/502 (2006.01) , A61K 31/505 (2006.01) , A61K 45/06 (2006.01) , A61P 11/00 (2006.01) | Title | Kombination af HMG-reduktaseinhibitor rosuvastatin med en phosphodiesterase-4-inhibitor, såsom roflumilast, roflumilast-N-oxid til behandlingen af inflammatoriske pulmonale sygdomme | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|